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http://dx.doi.org/10.1016/j.stemcr.2017.01.015SUMMARYHematopoietic stem cells (HSCs) are considered one of the most promising therapeutic targets for the treatment of various blood disor-
ders. However, due to difficulties in establishing stable maintenance and expansion of HSCs in vitro, their insufficient supply is a major
constraint to transplantation studies. To solve these problems we have developed a fully defined, all-recombinant protein-based culture
system. Through this system, we have identified hemopexin (HPX) and interleukin-1a as responsible for HSCmaintenance in vitro. Sub-
sequent molecular analysis revealed that HPX reduces intracellular reactive oxygen species levels within cultured HSCs. Furthermore,
bone marrow immunostaining and 3D immunohistochemistry revealed that HPX is expressed in non-myelinating Schwann cells,
known HSC niche constituents. These results highlight the utility of this fully defined all-recombinant protein-based culture system
for reproducible in vitro HSC culture and its potential to contribute to the identification of factors responsible for in vitro maintenance,
expansion, and differentiation of stem cell populations.INTRODUCTION
Hematopoietic stem cells (HSCs) maintain the ability to
self-renew and differentiate within their in vivomicroenvi-
ronment, the bone marrow (BM). From a clinical perspec-
tive, HSCs are important because they can generate the
full blood cell repertoire upon transplantation (Eaves,
2015) and are therefore critical determinants of clinical
BM transplant success. Additionally, in combination with
gene therapy approaches HSCs also offer the significant po-
tential to treat a range of inherited hematological disorders.
However, our ability to maintain and expand HSCs outside
of their in vivo microenvironment is currently limited.
The current protocols for ex vivo expansion of HSCs can
be broadly divided into two groups, based on their use of
cell-intrinsic or cell-extrinsic factors (Walasek et al., 2012).
Cell-intrinsic factors include exogenous expression tran-
scription factors such as HoxB4 (Sauvageau et al., 1995),
and chromatin remodeling factors such as Bmi1 (Iwama
et al., 2004). Such approaches have to date required genetic
modification that limits their direct translational applica-
tion. By contrast, cell-extrinsic factors such as cytokines
are simply added to the culture media and act on unmodi-
fied HSCs.
Cytokines and other extrinsic factors are present in
the specialized BM microenvironments, the so-called500 Stem Cell Reports j Vol. 8 j 500–508 j March 14, 2017 j ª 2017 The Aut
This is an open access article under the CC BY-NC-ND license (http://creativBM niche, and are thought to be involved in migration,
quiescence, and differentiation of HSCs (Kiel and Morri-
son, 2008). Many different cell types have been proposed
as the candidate for the BM niche, including osteoblasts
(Calvi et al., 2003; Zhang et al., 2003), endothelial
cells (Kiel et al., 2005), chemokine ligand 12 (CXCL12)-
abundant reticular cells (Sugiyama et al., 2006), mesen-
chymal stem cells (Mendez-Ferrer et al., 2010), and
non-myelinating Schwann glial cells (Yamazaki et al.,
2006, 2011).
BM niche cells are thought to secrete numerous factors
such as stem cell factor (SCF) (Barker, 1994) and thrombo-
poietin (TPO) (Ku et al., 1996), which are generally neces-
sary for HSC maintenance. These cytokines have long
been added to culture media to investigate HSC prolifera-
tion and reconstitution ability. However, there are con-
cerns about data reproducibility between laboratories,
with such discrepancies often being ascribed to differences
in experimental culture conditions.
HSCs have been widely analyzed using liquid or methyl-
cellulose culture in the presence of fetal bovine serum
(FBS). FBS contains myriad of growth factors, adhesion
molecules, and other components, and also protects cells
from rapid changes in pH.However, because of the high de-
gree of unknown factors, FBS is now often replaced with
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Figure 1. Heterogeneity in BSA-FV Lots
Affects HSC Maintenance
(A) Percentage of single CD34 HSCs forming
colonies after in vitro culture for 11 days with
cytokines and various BSA-FV lots. Mean ±
SEM from three independent experiments
(n = 30 per BSA-FV culture condition).
(B) Percentage peripheral blood (PB)
chimerism from 40 CD34KSL cells, cultured
for 1 week with cytokines and various BSA-FV
lots and transplanted into lethally irradi-
ated recipients together with 106 bone
marrow (BM) competitor cells. PB chimerism
12 weeks after transplantation. Mean ± SD of
three independent experiments (n = 10 mice
per BSA-FV culture condition).
(C and D) Protein analysis of total BSA-FV
(C) and albumin-depleted BSA-FV (D) by
SDS-PAGE.
(E) The ratio of proteins identified by HPLC-
MS analyses in different lots of BSA-FV (BSA-
FV #1, #8, #15), excluding albumin.the fifth ethanol fraction in the original purification
process of plasma proteins) (Guilbert and Iscove, 1976)
for in vitro HSC culture. BSA-based serum-free cultures
have been well established for pluripotent stem cells. How-
ever, stable in vitro expansion of HSCs remains difficult
and non-reproducible. This is at least in part due to the
use of different batches (lots) of BSA-FV by different
laboratories.
To address these issues, we tested 15 different lots of
commercially available BSA-FV; each exhibited different
abilities to maintain HSCs and unique protein profiles. To
identify the best molecular candidates for HSC mainte-
nance in BSA-FV, we developed a fully defined culture sys-
tem using all-recombinant proteins. Using this approach,
we provide evidence thatHSCmaintenance is strongly sup-
ported by two factors in BSA-FV, interleukin-1a (IL-1a) and
hemopexin (HPX). Further investigation found that HPX
reduced HSC intracellular reactive oxygen species (ROS)
levels and that HPX was present on non-myelinating
Schwann cells, a constituent of HSC niche in BM. These
findings highlight the utility of all-recombinant protein-
based systematic analysis for ex vivo HSC self-renewal
and differentiation, and identification of bona fide growth
factors that contribute to these cell-fate decisions.RESULTS
HSC Maintenance Depends on Varying Levels of
Unidentified Proteins Contained in BSA-FV
During our attempts at in vitro maintenance of HSCs, we
realized that different BSA-FV lots varied tremendously in
their colony-forming ability. We therefore evaluated 15
different lots of BSA-FV based on the ability to support
colony formation from single CD34- KSL HSCs (Osawa
et al., 1996). After 11 days in culture with each BSA-
FV lot, we confirmed that 5 out of 15 lots showed
very poor colony-formation ability (Figure 1A). We next
cultured HSCs with the remaining ten lots of BSA-FV
for 1 week and examined their blood system repopulating
potential using competitive repopulation assays. To our
surprise, different lots of BSA-FV varied in the ability to
accelerate HSC-mediated blood system reconstitution
(Figure 1B), and did not correlate with colony formation.
Culture in BSA-FV #1 resulted in peripheral blood (PB)
chimerism (at 12 weeks after the transplantation) of
more than 50%, while BSA-FV #15 cultured cells were
essentially undetectable. We hypothesized that these re-
sults were due to different compositions of unknown
factors in each lot of BSA-FV.Stem Cell Reports j Vol. 8 j 500–508 j March 14, 2017 501
To test this hypothesis, we attempted to detect the pres-
ence of unknown factors in BSA-FV using SDS-PAGE anal-
ysis. In addition to the major albumin protein, a number
of unidentified bands were detected in BSA-FV #1, #8,
and #15 (Figures 1C and 1D). Interestingly, in agreement
with lot-to-lot variability in band patterns, further high-
performance liquid chromatography-mass spectrometry
(HPLC-MS) analysis revealed that different lots of BSA-FV
exhibit distinct protein profiles (Figure 1E and Table S1).
These results suggest that differences in HSC maintenance
can be ascribed to varying levels of unidentified proteins
contained in BSA-FV.
HSC Maintenance Varies Depending on Different Lots
of BSA-FV
To assess the ability of BSA-FV to augment cytokine-medi-
ated HSC maintenance, we cultured 40 CD34KSL cells
in the presence of 1% BSA-FV, SCF, TPO, and 30 different
individual ligands. These 30 ligands were selected based
on the expression of their receptors on CD34 HSCs,
identified from a previously published DNA microarray
expression dataset. After 1 week, cultured cells were then
transplanted into lethally irradiated recipient mice along
with competitor cells and the ratio of PB chimerism deter-
mined 12 weeks after transplantation. To our surprise, the
effect of each cytokine on the maintenance of HSCs
changed dramatically when different BSA-FV lots were
used. For instance, although IL-11 was reported to promote
the growth of primitive hematopoietic progenitors in
cooperation with IL-4 (Jacobsen et al., 1995), the ratio of
chimerism induced by IL-11 was higher than that of con-
trol when BSA-FV #1 was used (Figure 2A), but the opposite
result was obtained for BSA-FV #8 (Figure 2B). In addition,
PB chimerism was detected in the presence of epidermal
growth factor, insulin-like growth factor 2, or platelet-
derived growth factor (PDGF) when BSA-FV #1 was used,
whereas we could not observe any PB chimerism under
the same conditions when BSA-FV #8 was used. From the
viewpoint of reproducibility, these results suggest that sim-
ple addition of BSA-FV to cell culture should be reconsid-
ered for efficient in vitro maintenance of HSCs. To further
confirm these results, we repeated the same experiment
focusing on IL-1a, CXCL10, IL-4, and IL-11. The results
clearly demonstrated that, as was the case for IL-1a, the ef-
fect of the cytokine on the ratio of PB chimerism depended
on the BSA-FV lot (Figures 2C and 2D).
Recombinant Protein-Based Culture Is a Promising
Standard Culture System for HSC Maintenance and
Expansion
To improve reproducibility in HSC proliferation, we estab-
lished a standard BSA-FV free HSC culture system. After
trial and error, we focused on a purified recombinant serum502 Stem Cell Reports j Vol. 8 j 500–508 j March 14, 2017albumin (RSA). We first analyzed the effect of four different
RSAs on HSCmaintenance and the ratio of chimerism (Fig-
ure 3A). Although RSA produced by rice (#C and #D) did
not show any effect, RSA produced by yeast (#A and #B) ex-
hibited repopulation ability and multi-lineage output (Fig-
ure S1A), regardless of lot or manufacturer. Furthermore,
humanRSA (HSA) andmouse RSA (MSA) produced by yeast
equally maintained HSC reconstitution ability and multi-
lineage output (Figures 3B and S1B). These results indicate
that culture conditions containing RSA could be a prom-
ising candidate for recombinant protein-based culture
systems.
To assess the ability of HSC to proliferate in RSA cultures,
we compared single HSC growth in RSA- and BSA-FV #8-
based cultures. RSA-cultured HSCs exhibited growth ki-
netics equivalent to those cultured in BSA-FV #8 (Fig-
ure 3C). HSCs were also cultured with RSA for 1 week,
and tested for their potential to reconstitute the blood sys-
tem. We found that the ratio of PB chimerism after the
transplantation was lower than that of BSA-FV #1, but
similar to that of BSA-FV #8 (Figure 3D). RSA-, as well as
BSA-FV #1- and #8-cultured HSCs, all displayed increased
PB chimerism following transplantation over freshly iso-
lated CD34KSL HSCs (Figure 3D). A 7-day culture with
RSA increased PB chimerism by approximately 2-fold.
Using the above recombinant protein-based culture sys-
tem, we reassessed the effect of the 30 ligands to maintain
HSCs ex vivo. These experiments identified several factors
that increased the ratio of PB chimerism at 12 weeks after
transplantation (Figure 3E). These results were distinct
from the BSA-FV-based cultures, highlighting the BSA-
mediated augmentation of ligand effects. Among these 30
ligands we focused on IL-1a, which exhibited highly
elevated reconstitution ability when added to the RSA-
based culture. IL-1a has been previously reported to sup-
press colony formation of mouse KSL cells (Yonemura
et al., 1996). However, competitive repopulation assays af-
ter in vitro culture showed a significantly higher ratio of PB
chimerism compared with controls (Figures S2A and S2B).
In addition, 16 weeks after transplantation we performed
secondary transplantation and found that IL-1a exhibits
much higher levels of chimerism than controls (Fig-
ure S2C). As IL-1a did not alter the proliferation kinetics
of HSCs in vitro (Figure S2D), these findings strongly sug-
gest that IL-1a is a bone fide HSC maintenance factor.
Hemopexin Contained in BSA-FV Is Responsible for
HSC Maintenance
HSCmaintenance factors may not necessarily be ligands of
receptors expressed onHSCs. As shown in Figure 1E, HPLC-
MS analysis of BSA-FV #1, #8, and #15 revealed distinct
protein profiles. Integrating these protein profiles with









































































































































































































































































































Figure 2. The Ratio of Peripheral Blood
Chimerism Depends on BSA-FV Lot
(A and B) Percentage PB chimerism from 40
CD34KSL HSCs cultured for 1 week in the
presence of 30 different cytokines, SCF, TPO,
and BSA-FV #1 (A) or #8 (B), and trans-
planted into lethally irradiated recipient
mice together with 106 BM competitor cells.
PB chimerism at 12 weeks after trans-
plantation (n = 5 mice per BSA-FV culture
condition). Mean ± SD from two independent
experiments, calculated as a ratio relative
to SCF + TPO only conditions.
(C and D) As above, but displayed as per-
centage PB chimerism for selected cytokines
(IL-1a, CXCL10, IL-4, IL-11) cultured with
1% BSA-FV #1 (C) or #8 (D) between 4 and
24 weeks post transplantation.putative HSC maintenance factors for investigation with a
recombinant protein-based culture system. To determine
the functional significance of these factors, we prepared
recombinant proteins and assessed their effect on HSC
repopulating ability by competitive repopulation assays
following 1 week of culture with or without each recombi-
nant protein.
One factor tested by this system, HPX, significantly
increased levels of PB chimerism when added to the
in vitro HSC culture in both primary and secondary trans-
plantation recipients (Figures 4A, 4B, and S3A). Further
studies demonstrated that as little as 5 ng/mL HPX could
induce this increase in HSC repopulating ability (Fig-
ure S3B). To assess whether HPX is present in other lots
of BSA-FV, we analyzed HPX levels in different lots ofBSA-FV by western blotting, and found that three out of
eight BSA-FV lots (#A, #B, and #H) contained a significant
amount of HPX (Figure 4C). Consistent with this observa-
tion, competitive repopulation assays clearly demonstrated
that HSCs cultured with HPX-positive BSA-FV exhibited
higher chimerism than HPX-negative controls (Figure 4D).
HPX is a heme-binding plasma glycoprotein (Muller-
Eberhard, 1988) that prevents heme-mediated oxidative
stress (Tolosano and Altruda, 2002). Given the described
negative effects of ROS on HSC function, we hypothesized
that HPX enhances HSC function through inhibiting
oxidative stress. We therefore evaluated the in vitro effect
of HPX on ROS production in HSCs (Figure S3C). Consis-
tent with our hypothesis, we observed a significant reduc-







































































































































































































Figure 3. Recombinant Serum Albumin
Can Replace BSA-FV for Ex Vivo Culture of
HSCs
(A) Percentage PB chimerism from 40
CD34KSL cells, following 1 week of culture
with cytokines and 1% RSA produced by
either yeast (A and B) and rice (C and D). PB
chimerism 12 weeks after transplantation
into lethally irradiated recipients together
with 106 BM competitor cells (n = 8 mice per
RSA culture condition). Mean ± SD from two
independent experiments.
(B) As in (A) but cultured with 1% MSA
or HSA. Mean ± SD from three independent
experiments (n = 8 mice per RSA culture
condition).
(C) Single CD34KSL HSCs were cultured for
1 week in 96-well microtiter plates in S-Clone
SF-03 supplemented with SCF, TPO, and 1%
BSA-FV #8 (gray line) or RSA (black line). Cell
numbers were counted every 24 hr under a
microscope. Mean ± SEM (n = 40 per RSA
culture condition).
(D) As in (A) but for either freshly isolated
HSCs cultured for 7 days with 1% BSA-FV #1,
#8, #15, or RSA. Mean ± SD from two inde-
pendent experiments (n = 10 mice per RSA
culture condition).
(E) Percentage PB chimerism of 40 CD34KSL
HSCs (cultured for 1 week in the presence
of different cytokines, SCF, TPO, and RSA)
12 weeks after transplantation into lethally
irradiated recipient mice together with 106
BM competitor cells. Mean ± SD from two
independent experiments (n = 5 mice per
cytokine culture condition), calculated as a
ratio relative to SCF + TPO only conditions.
Statistical significance denoted by **p <
0.05, ***p < 0.005, or N.S. (not significant)
as determined by unpaired t test.with control cultured HSCs (Figure 4E). HPX did not
alter HSC proliferation kinetics in vitro (Figure S3D), high-
lighting that HPX enhances HSC maintenance rather than
cell proliferation.
HPX expression has previously been reported in liver,
CNS, retina, and peripheral nerves (Chen et al., 1998;
Swerts et al., 1992; Tolosano et al., 1996). Given that pe-
ripheral nerves include non-myelinating Schwann cells,
which are also a constituent of HSC niche (Yamazaki
et al., 2011), we were interested in whether this BM
cell type also expressed HPX. We therefore investigated
HPX expression by immunostaining BM sections along
with glial fibrillary acidic protein (GFAP) expression, and
confirmed overlapping expression of HPX and GFAP in
all sections (Figures 4F and 4G). Furthermore, using a504 Stem Cell Reports j Vol. 8 j 500–508 j March 14, 2017recently developed whole-body imaging by tissue decolor-
ization technique, we performed 3D immunohistochem-
istry of whole BM and further confirmed co-localization
of HPX and GFAP (Figure 4H and Movie S1). While the
majority of HPX co-localized with GFAP, HPX staining
was also seen elsewhere within the BM, suggesting that
other BM niche cells express HPX. These results raise the
intriguing possibility that HPX protects HSCs from oxida-
tive stress in specialized BM niches, although further
work is necessary to define the role of HPX in vivo.
Finally, we attempted to quantitate the effects of HPX
and IL-1a on in vitro HSC maintenance and expansion us-
ing limiting dilution analysis by transplanting 1,000, 100,
and 10 cells (following a 7-day culture) alongside 2 3 105
BM competitors. Surprisingly, all mice displayed significant

























































































Figure 4. The All-Recombinant Protein-Based Culture System Contributes to Identification of HSC Maintenance Factors Contained
in BSA-FV
(A and B) The percentage PB chimerism from 40 CD34KSL HSCs following culture for 1 week in the presence SCF, TPO, RSA, and with or
without HPX (10 ng/mL) before transplantation into lethally irradiated recipient mice together with 106 BM competitor cells. PB
chimerismmeasured over 24 weeks post transplantation (n = 4 or 5 mice per culture condition) and displayed as total PB chimerism (A) and
blood-lineage chimerism (B) within the myeloid (Gr-1/Mac-1+), B cell (B220+), and T cell (CD3+) lineages at 12 weeks. Mean ± SD from two
independent experiments.
(legend continued on next page)
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donor cell chimerism (>90% in some mice) within the PB
after 4 weeks (Figure S4). While these results precluded
quantitation of HSC frequency, they do highlight the abil-
ity of RSA-based cultures to expand blood system reconsti-
tuting cells in vitro. After all, single HSCs on average give
rise to approximately 200 progenies during the 7-day RSA
culture (Figure 3C), yet substantial PB chimerism was de-
tected from aliquots of 100 and 10 HSC progenies (1/2
and 1/20 HSC equivalents, respectively).DISCUSSION
Reproducibility is of central importance in experimental
science. Unfortunately, in the case of in vitro maintenance
ofHSCs, reproducible results are oftennot obtained. Several
factors are likely responsible, including the variability of
culture reagents, insufficient culture conditions, and (im)
purity of phenotypic HSCs. Data presented here highlight
the wide variety of in vitro HSC maintenance capabilities
of different BSA-FV preparations. To overcome these limita-
tions, we have developed a fully defined all-recombinant
protein-based system for the in vitro culture of murine
HSCs. Using this system, we have demonstrated that IL-1a
and HPX, often contained within BSA-FV, significantly
enhance in vitro maintenance of HSCs. This system there-
fore provides a basis on which to develop a reproducible
in vitro HSC maintenance and expansion culture system.
Development of stable in vitro expansion conditions for
HSCs would have important implications for both basic
research and clinical use. In particular, stable ex vivo
expansion of HSCs would reduce current shortages in do-
nors for clinical BM transplantation and could afford
ex vivo gene correction approaches for inherited hemato-
logical disorders. Furthermore, recent efforts to generate
HSCs in vitro by directed differentiation and reprogram-
ming are currently limited by our inability to maintain
any HSCs generated in vitro. Here, we propose an all-re-
combinant protein-based system with which to develop
such culture conditions, and systematic approaches by
which to develop optimal conditions.
Based on DNA microarray data, we tested the functions
of 30 different candidate factors by adding them one(C) Immunoblotting for HPX of albumin-depleted BSA-FV.
(D) Lethally irradiated recipient mice were transplanted with 106 BM c
BSA-FV or 1% RSA with or without HPX (all in the presence of SCF and T
5 mice per BSA-FV culture condition). Mean ± SD of three independe
(E) Effect of HPX on ROS levels of in vitro cultured HSCs, as measured
intensity (MFI) values ± SD (n = 5 per culture condition).
(F and G) Fluorescence imaging of BM sections co-stained with anti-H
(F) 100 mm; (G) 4 mm.
(H) 3D fluorescence image of a representative tibia BM, stained with
Statistical significance denoted by **p < 0.05 and ***p < 0.005 as d
506 Stem Cell Reports j Vol. 8 j 500–508 j March 14, 2017by one to HSC culture medium. Consequently, we were
able to identify two HSC maintenance factors, IL-1a and
HPX. In previous studies, IL-1a was reported to support
the proliferation of mouse HSCs in cooperation with IL-3
(Jubinsky and Stanley, 1985; Mochizuki et al., 1987), while
another group reported that the same factor reduces
the colony-forming and reconstitution ability of HSCs
(Yonemura et al., 1996). These contradictory results
highlight the problems of using variable reagents such
as conditioned medium or FBS. In the present study,
we were able to reveal that IL-1a in fact contributes to the
PB reconstitution potential of HSCs (Figures S1A and
S1B). However, we note that high concentrations of IL-1a
(100 ng/mL) inhibited colony formation (data not shown).
Furthermore, we were able to identify HPX as an HSC
maintenance factor contained within BSA-FV. HPX is
thought to inhibit heme-induced ROS generation. While
hematopoietic defects in HPX knockout mice have not
been described (Tolosano et al., 1999), our results demon-
strated that HPX reduced ROS level of cultured HSCs and
improved their reconstitution capability. HPX is unlikely
to be the only HSC maintenance factor in BSA-FV, and we
believe that protein profiling of ‘‘good’’ BSA-FV batches,
as described here, will allow further identification of novel
HSC maintenance and expansion factors.
In conclusion, we believe that the all-recombinant pro-
tein-based system described here is an exciting research
tool for generating highly robust and reproducible data,
and one that will provide important contributions in
our efforts to identify growth and differentiation factors for
HSCs, as well as many other different stem cell populations.EXPERIMENTAL PROCEDURES
HSC Purification
Mouse CD34KSL HSCs were purified from BM cells of 8- to 10-
week-old mice. See Supplemental Experimental Procedures for a
detailed description.HSC Culture
CD34KSLHSCswere deposited into 96-well microtiter plates con-
taining 200 mL of serum-free medium S-Clone SF-03 (Sankoompetitor cells and 40 CD34KSL HSCs cultured for 1 week with 1%
PO). Percentage PB chimerism at 12 weeks post transplantation (n =
nt experiments.
by flow cytometric analysis of HySOx staining. Mean fluorescence
PX (red), anti-GFAP (green), and DAPI (blue) antibodies. Scale bars:
anti-HPX (red) and anti-GFAP (green). Scale bar, 150 mm.
etermined by unpaired t test.
Junyaku) supplemented with 1% BSA (Sigma and Wako), MSA,
or HSA (Albumin Bioscience, Sigma, Bioverde) and cytokines
(50 ng/mL mouse SCF, 50 ng/mL human TPO).Competitive Repopulation Assays
Competitive repopulation assays were performed using the Ly5
congenic mouse system. Forty CD34KSL cells from B6-Ly5.1
and the BM competitor cells (13 106) from B6-F1mice were trans-
planted into B6-Ly5.2 mice irradiated at a dose of 9.8 Gy. See Sup-
plemental Experimental Procedures for a detailed description.Sample Purification for Mass Spectrometry
Depletion of albumin from BSA-FV was performed using Melon
Gel IgG Spin Purification Kit (Thermo Scientific) according to the
manufacturer’s instructions.BM Immunofluorescence and 3D Imaging
Frozen BM sections were prepared and immunostained according
to the Kawamoto method (Kawamoto, 2003). 3D imaging was per-
formed as previously described (Susaki et al., 2015).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, one table, and one movie and can be
found with this article online at http://dx.doi.org/10.1016/j.
stemcr.2017.01.015.
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